$3.43 Billion is the total value of MSD Partners, L.P.'s 34 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 33.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SPY | New | SPDR S&P 500 ETF TRcall | $2,120,381,000 | – | 8,440,000 | +100.0% | 61.90% | – |
SPY | Buy | SPDR S&P 500 ETF TRput | $200,984,000 | +53.6% | 800,000 | +47.9% | 5.87% | -27.9% |
MIC | Sell | MACQUARIE INFRASTRUCTURE COR | $156,125,000 | -13.7% | 2,162,991 | -6.2% | 4.56% | -59.5% |
AABA | Sell | ALTABA INC | $154,908,000 | -36.5% | 2,338,587 | -47.8% | 4.52% | -70.2% |
SSNC | Sell | SS&C TECHNOLOGIES HLDGS INC | $107,209,000 | -2.0% | 2,670,208 | -6.2% | 3.13% | -54.0% |
COTY | COTY INC | $97,536,000 | -11.9% | 5,900,523 | 0.0% | 2.85% | -58.7% | |
NXST | Sell | NEXSTAR MEDIA GROUP INCcl a | $87,048,000 | -44.2% | 1,397,247 | -46.4% | 2.54% | -73.8% |
APO | Buy | APOLLO GLOBAL MGMT LLC | $67,274,000 | +32.8% | 2,235,009 | +16.7% | 1.96% | -37.7% |
QSR | Sell | RESTAURANT BRANDS INTL INC | $60,098,000 | -31.9% | 940,800 | -33.3% | 1.75% | -68.1% |
HALO | HALOZYME THERAPEUTICS INC | $38,996,000 | +35.5% | 2,245,000 | 0.0% | 1.14% | -36.5% | |
FUN | Sell | CEDAR FAIR L Pdepositry unit | $38,515,000 | -66.6% | 600,665 | -62.4% | 1.12% | -84.3% |
FWONK | LIBERTY MEDIA CORP DELAWARE | $38,090,000 | +4.0% | 1,000,000 | 0.0% | 1.11% | -51.2% | |
REI | RING ENERGY INC | $37,504,000 | +11.5% | 2,588,266 | 0.0% | 1.10% | -47.7% | |
HRG | Sell | HRG GROUP INC | $32,817,000 | -35.0% | 2,102,335 | -26.3% | 0.96% | -69.5% |
NGHC | NATIONAL GEN HLDGS CORP | $22,215,000 | -9.4% | 1,162,500 | 0.0% | 0.65% | -57.5% | |
ZIOP | ZIOPHARM ONCOLOGY INC | $20,940,000 | -1.3% | 3,410,500 | 0.0% | 0.61% | -53.7% | |
XOP | New | SPDR SERIES TRUSTcall | $20,454,000 | – | 600,000 | +100.0% | 0.60% | – |
BKEP | BLUEKNIGHT ENERGY PARTNERS L | $18,561,000 | -8.8% | 3,256,390 | 0.0% | 0.54% | -57.2% | |
NG | NOVAGOLD RES INC | $17,445,000 | -9.6% | 4,234,129 | 0.0% | 0.51% | -57.6% | |
TRCO | TRIBUNE MEDIA COcl a | $14,914,000 | +0.2% | 365,000 | 0.0% | 0.44% | -53.0% | |
GASS | STEALTHGAS INC | $12,276,000 | +1.8% | 3,708,819 | 0.0% | 0.36% | -52.3% | |
IPG | INTERPUBLIC GROUP COS INC | $10,881,000 | -15.5% | 523,395 | 0.0% | 0.32% | -60.3% | |
BMCH | BMC STK HLDGS INC | $10,293,000 | -2.3% | 482,088 | 0.0% | 0.30% | -54.2% | |
MRTN | Buy | MARTEN TRANS LTD | $10,275,000 | +25.0% | 500,000 | +66.7% | 0.30% | -41.3% |
JPM | JPMORGAN CHASE & CO | $7,163,000 | +4.5% | 75,000 | 0.0% | 0.21% | -50.9% | |
C | CITIGROUP INC | $7,130,000 | +8.8% | 98,023 | 0.0% | 0.21% | -49.0% | |
EZPW | EZCORP INCcl a non vtg | $6,792,000 | +23.4% | 715,000 | 0.0% | 0.20% | -42.3% | |
SYN | SYNTHETIC BIOLOGICS INC | $3,843,000 | +65.0% | 4,118,402 | 0.0% | 0.11% | -22.8% | |
FCSC | FIBROCELL SCIENCE INC | $2,120,000 | -23.7% | 692,960 | 0.0% | 0.06% | -64.2% | |
EGLTQ | New | EGALET CORP | $1,357,000 | – | 1,060,100 | +100.0% | 0.04% | – |
OGEN | ORAGENICS INC | $724,000 | +13.5% | 1,725,000 | 0.0% | 0.02% | -47.5% | |
New | NABRIVA THERAPEUTICS PLC | $410,000 | – | 50,000 | +100.0% | 0.01% | – | |
ITCI | New | INTRA CELLULAR THERAPIES INC | $394,000 | – | 25,000 | +100.0% | 0.01% | – |
APHB | AMPLIPHI BIOSCIENCES CORP | $14,000 | +16.7% | 15,011 | 0.0% | 0.00% | -100.0% | |
NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -67,600 | -100.0% | -0.03% | – |
VRTV | Exit | VERITIV CORP | $0 | – | -28,383 | -100.0% | -0.08% | – |
KRNT | Exit | KORNIT DIGITAL LTD | $0 | – | -103,300 | -100.0% | -0.12% | – |
CDZI | Exit | CADIZ INC | $0 | – | -336,699 | -100.0% | -0.28% | – |
NYRT | Exit | NEW YORK REIT INC | $0 | – | -746,800 | -100.0% | -0.40% | – |
VST | Exit | VISTRA ENERGY CORP | $0 | – | -2,024,921 | -100.0% | -2.12% | – |
USFD | Exit | US FOODS HLDG CORP | $0 | – | -2,007,170 | -100.0% | -3.40% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ZIOPHARM ONCOLOGY INC | 42 | Q3 2023 | 15.7% |
JPMORGAN CHASE & CO | 42 | Q3 2023 | 2.3% |
STEALTHGAS INC | 39 | Q3 2023 | 2.8% |
COOPER STD HLDGS INC | 29 | Q2 2022 | 3.0% |
CITIGROUP INC | 28 | Q3 2023 | 1.4% |
NATIONAL GEN HLDGS CORP | 26 | Q3 2020 | 15.3% |
MARTEN TRANS LTD | 26 | Q3 2019 | 1.1% |
SYNTHETIC BIOLOGICS INC | 21 | Q2 2018 | 0.5% |
COTY INC | 20 | Q4 2018 | 7.4% |
BLUEKNIGHT ENERGY PARTNERS L | 19 | Q4 2017 | 1.7% |
View MSD Partners, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Alaunos Therapeutics, Inc. | February 14, 2023 | 15,151,516 | 7.0% |
Hayward Holdings, Inc. | February 14, 2023 | 71,538,085 | 33.9% |
Independence Contract Drilling, Inc. | February 14, 2023 | 2,960,406 | 19.9% |
PIONEER ENERGY SERVICES LLC | February 14, 2023 | ? | ? |
PLx Pharma Inc. | February 14, 2023 | 686,685 | 2.4% |
Independence Contract Drilling, Inc. | December 22, 2022 | 2,822,336 | 19.5% |
BrightView Holdings, Inc. | March 17, 2022 | ? | ? |
Imperial Petroleum Inc./Marshall Islands | February 14, 2022 | 439,581 | 3.1% |
MESA AIR GROUP INC | February 14, 2022 | 264,723 | 0.7% |
National General Holdings Corp. | February 12, 2021 | ? | ? |
View MSD Partners, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
40-APP | 2024-04-11 |
4 | 2024-03-08 |
13F-HR/A | 2024-02-20 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
4 | 2023-12-14 |
View MSD Partners, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.